Kunwha Pharmaceutical, The stock price drops to the lowest limit due to recapitalization to raise funds to take over Dream Pharma
Kunwha Pharmaceutical posted a notice of KRW 134.345 billion worth of recapitalization to raise funds to take over 100% shares of the drug manufacturing corporation divided from Dream Pharma.
The number of the newly issued shares is 9.7 million shares, and the number of new stock allotment per a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
